Blackstrap Molasses

Clinical Summary

Blackstrap molasses is the concentrated syrup from the third boiling of sugarcane juice — the final byproduct of sugar refining. It retains the minerals stripped during crystallization: Iron (3.6 mg/tbsp, 20% RDA), Potassium (293 mg), Magnesium (48 mg), Calcium (41 mg), Copper (0.1 mg), and manganese (0.5 mg). It also contains phenolic acids (protocatechuic, vanillic, caffeic, ferulic, p-coumaric) with demonstrated in vitro antioxidant activity.

The evidence base is thin. Only two human RCTs exist: one showing blackstrap molasses is non-inferior to PEG 3350 for pediatric functional constipation (PMID: 30946967, N=92, 2019), and one showing grape molasses (not blackstrap) has comparable iron absorption to ferrous sulfate in children (PMID: 9433148, N=56, 1997). No adult RCTs exist for any indication. No meta-analyses. All other claimed benefits — antioxidant effects, bone health, cardiovascular benefits, gray hair reversal, cancer prevention, detoxification — lack human clinical evidence.

The primary trade-off is mineral content versus sugar burden: each tablespoon delivers 11 g sugar (58 kcal). This makes it inappropriate for diabetes and metabolic syndrome, and limits its role as a mineral supplement. For mild iron deficiency in people who cannot tolerate ferrous sulfate, blackstrap molasses is a reasonable, affordable, well-tolerated whole-food alternative. For everything else, targeted supplements are more effective at lower caloric cost.

Sugarcane polyphenol research is an active area in Japanese universities (University of the Ryukyus, Kagoshima University), with several in vitro studies on antioxidant fractions — but zero human clinical translation to date.

Indications & Evidence

Reading this table: Stars = evidence volume. Type = what kind of evidence (see legend). BH = Bradford Hill causal strength (/9). Safety = FAERS/trial signals for THIS specific indication. One row = one decision.

Hard rule: Star rating cannot exceed the causal taxonomy ceiling for its Type. E.g., Type=ME (mechanistic extrapolation) caps at 2/5 regardless of how many in vitro studies exist.

Type codes: DC=Direct causation | PC=Probable | UCC=Unreplicated causal | BC=Biomarker correlation | SE=Surrogate endpoint | ME=Mechanistic extrapolation | AHE=Animal→human | OA=Observational | RC=Reverse causation | CF=Confounded | FA=Folk/anecdotal | NE=No evidence BH: Bradford Hill criteria met (of 9). 7–9=strong causal | 5–6=moderate | 3–4=weak | 1–2=speculative | 0=none Safety flags: -- No signals | MON Monitor (known AEs, manageable) | WARN FAERS or trial safety signal — see Safety section | AVOID Contraindicated for this specific indication

Star rating legend: 5/5 Multiple large RCTs + MA | 4/5 Several human RCTs | 3/5 Some human pilot/one small RCT | 2/5 Animal data or very limited human | 1/5 None/theoretical/debunked

Prescribing

Dosing Table

Contraindicated: Infants <1 year (unlike honey, the refining process likely kills C. botulinum spores — but avoided precautionarily + unnecessary sugar exposure), hemochromatosis, CKD Stage 4–5, uncontrolled diabetes (HbA1c >8%).

Formulation Table

Preferred: Unsulphured blackstrap. Organic optional (no mineral difference; reduces pesticide traces). Mineral content varies significantly by brand, soil, and processing — no USP standardization exists.

Safety

Interactions Table

Contraindications

• Absolute: Hereditary hemochromatosis (HFE mutations), severe CKD (GFR <30), diagnosed sulfite allergy (sulphured only)
• Relative: Uncontrolled diabetes (HbA1c >8%), NAFLD/NASH, moderate CKD (GFR 30–60, limit dose), active IBD flare (osmotic diarrhea risk), reactive hypoglycemia, Sjögren's syndrome (sugar + xerostomia → high caries risk)

Adverse Effects

FAERS Signal Table (from BioMCP)

Interpretation: FAERS data is pure noise for molasses. All 15 reports list molasses as a concomitant product consumed alongside suspect pharmaceuticals. No safety signal attributable to molasses itself.

Monitoring Table

Special Populations

Pregnancy: FDA GRAS as food. No teratogenicity data. Max 1 tbsp/day. Sugar burden concern in gestational diabetes. Prenatal vitamin with iron preferred for reliable dosing. Choose organic/third-party tested for contaminant minimization.

CKD Stage 3b–4 (GFR 15–44): Reduce to 0.5–1 tbsp/day max. Potassium is the limiting mineral (293 mg/tbsp; impaired excretion → hyperkalemia → cardiac arrhythmia). Iron content actually beneficial for CKD anemia. Monthly K⁺ monitoring. Nephrologist supervision if GFR <30.

Hepatic impairment: No hepatotoxicity. Child-Pugh A–B: standard dosing. Child-Pugh C: limit 0.5–1 tbsp (insulin resistance). NAFLD/NASH: limit to 0.5 tbsp or avoid (fructose worsens steatosis).

Synergies & Stacking

Optimal iron-absorption stack: 2 tbsp molasses + 100 mg Vitamin C + lean protein meal. Avoid coffee, tea, calcium supplements within 2 hours.

Antagonistic: Calcium supplements (compete for DMT1), coffee/tea (tannin chelation), phytates (whole grains, unsoaked legumes), oxalates (spinach, Swiss chard).

Individual Response Modifiers

Sex-Specific Considerations

Key studies (PMID: 9433148, 30946967) were conducted in mixed-sex pediatric populations. No adult sex-stratified data exists for molasses.

Genetic Modifiers

No known pharmacogenomic modifiers specific to blackstrap molasses. The compound is a food matrix delivering common minerals — individual mineral pharmacogenomics (e.g., HFE variants for iron, VDR for calcium) apply but are not unique to molasses:

• HFE C282Y/H63D: Iron overload risk — absolute contraindication for molasses if homozygous
• MTHFR C677T: No relevance (molasses contains no folate)
• BCMO1 variants: No relevance (no beta-carotene content)

Community & Anecdotal Evidence

Disclaimer: This section captures real-world user reports from online communities. None of this constitutes clinical evidence. N-sizes are approximate. Selection bias, placebo effect, and recall bias are inherent. Presented for completeness, not as medical guidance.

Dominant Sentiment

Positive to polarized across ~5,000+ reports (Reddit, EarthClinic, Lipstick Alley, Long Hair Care Forum, TikTok, YouTube).

What Users Report

Community Dosing vs Clinical

Popular Stacks (Community)

Red Flags & Skepticism Notes

• MLM involvement: None detected. Blackstrap molasses is a commodity food, not an MLM product.
• Influencer concentration: Moderate. Gray hair reversal claims amplified by a small number of YouTube/TikTok creators generating content revenue. "BSM cures cancer" claims are fringe but persistent.
• Astroturfing signals: None detected. Reports appear genuinely user-generated across diverse platforms.
• Commercial bias: Low. Molasses is cheap ($0.08–0.30/serving). No major supplement company pushes it. Content creators may earn ad revenue but no affiliate structures identified.

Folk vs Clinical Reality Check

Community experience aligns with clinical data on two points: iron deficiency symptom relief (supported by PMID 9433148) and improved bowel regularity (supported by PMID 30946967). The gray hair reversal claim — by far the most popular folk claim — has zero clinical evidence. The theoretical mechanism (copper → melanin synthesis) is plausible but the dose is far too low: 0.1 mg copper per tablespoon is only 10% RDA, and established graying involves melanocyte stem cell depletion, not simple copper deficiency. The most likely explanation for perceived hair darkening in some users is correction of previously undiagnosed copper or iron deficiency (rare), placebo/confirmation bias, or natural variation in graying pace.

Deep Dive: Mechanisms & Research

Iron Provision & Absorption

Blackstrap molasses provides non-heme iron (Fe³⁺) at 3–4 mg per tablespoon. Unlike heme iron (20–30% absorption), non-heme iron has 2–10% bioavailability, requiring reduction to Fe²⁺ by duodenal cytochrome B (DcytB) before DMT1 transport. Molasses contains natural absorption enhancers — organic acids (citric, malic) that chelate iron and maintain solubility, and sugars (fructose) that may enhance DMT1 activity. Low phytate content is an advantage over grain-based iron sources. Absorption is regulated by hepcidin; when stores are replete, excess is blocked (PMID: 20200263).

Phenolic Compound Profile

Japanese research has characterized sugarcane molasses phenolics extensively. Asikin et al. (Kagoshima University) identified 10 phenolic constituents via bioassay-guided fractionation, with ORAC values of 4,399–6,266 μmol TE/g — significant in vitro activity (PMID: 23768381). Two novel neolignan glucosides with DNA damage protection activity were isolated at the University of the Ryukyus (PMID: 25865605). Takara et al. identified 9 antioxidative phenolic glycosides from kokuto (non-centrifuged cane sugar) (PMID: 11866116, 12729002).

A USDA study by Phillips et al. confirmed blackstrap molasses has the highest antioxidant content (ORAC 4,699 μmol TE/100 g) of any commercial sweetener tested — higher than honey, maple syrup, corn syrup, or agave (PMID: 19103324). Takara et al. also demonstrated antibacterial activity of molasses phenolics against Streptococcus mutans and other cariogenic bacteria in vitro (PMID: 17938552).

Critical gap: All phenolic research is in vitro. No human bioavailability, pharmacokinetic, or clinical outcome studies exist for molasses-derived phenolics.

Immunomodulation (Emerging)

One ex vivo human study (PMID: 31780030, 2019, Iran) showed sugarcane molasses enhanced TGF-β secretion and FOXP3 (Treg marker) gene expression in peripheral blood mononuclear cells from ulcerative colitis patients stimulated with Bifidobacterium. This is the only human-tissue immunology data and suggests anti-inflammatory potential — but it is ex vivo, not a clinical trial.

Anti-Atherosclerotic Effect (Animal)

Kokuto (Okinawan non-centrifuged cane sugar, functionally equivalent to blackstrap molasses) significantly prevented atherosclerosis in Japanese quail fed an atherogenic diet (PMID: 19072226, 2009, University of the Ryukyus). The active agents were phenolic compounds, not policosanol. Negative correlation between radical scavenging activity and atherosclerosis degree.

Hepatoprotection (Animal)

A 2025 Chinese study (PMID: 40362898) showed sugarcane molasses polyphenol extract attenuated alcohol-induced chronic liver damage in mice via antioxidant and anti-inflammatory pathways (CYP2E1/Keap1/NF-κB modulation). Preclinical only.

Anti-Stress Effect (Animal)

Non-sugar fraction of kokuto suppressed serum corticosterone in restraint-stressed mice and prevented stress-induced antioxidant depletion in serum and liver (PMID: 30651413, 2019, Kagoshima University + University of the Ryukyus). Active compounds: p-hydroxybenzaldehyde, schaftoside, isoschaftoside, p-coumaric acid.

Policosanol Distinction

Policosanol is derived from sugarcane wax (outer cane surface), NOT from molasses. While there may be trace amounts in blackstrap molasses, it is not a significant source. The policosanol lipid-lowering literature (meta-analysis PMID: 28730734) is largely separate and should not be conflated with molasses research. Independent replications of Cuban policosanol studies have failed to confirm efficacy.

Constipation Mechanism

The 2019 Iranian RCT (PMID: 30946967) demonstrated BSM's laxative effect at 1 mL/kg/day in children. Mechanism is likely multifactorial: osmotic effect of concentrated sugars drawing water into the intestinal lumen, magnesium's mild laxative action, and possibly phenolic compounds influencing gut motility. BSM was non-inferior to PEG 3350 (the gold-standard osmotic laxative) with no observed side effects.

Glycemic Index Modification

Wright et al. (PMID: 25373842) showed that filtered molasses concentrate (FMC) — a proprietary processed extract, not standard blackstrap molasses — reduced postprandial glucose by 5–20% and insulin response when added to high-carb foods. This was dose-dependent and attributed to phenolics and minerals affecting carbohydrate metabolism. The study was industry-funded (Horizon Science Pty. Ltd). Standard blackstrap molasses has GI ~55 (moderate) and has NOT been shown to have this effect.

Clinical Trials (from BioMCP / ClinicalTrials.gov)

No trials with blackstrap sugarcane molasses as the active intervention are currently recruiting. The BSM constipation RCT (PMID: 30946967) was not registered on ClinicalTrials.gov (published in Iran). No trials found on JPRN (Japan), CRiS (Korea), or ChiCTR (China) registries.

Regulatory Status (from BioMCP)

• FDA: Not a drug. GRAS (Generally Recognized As Safe) as a food product. BioMCP entity: CHEBI:83163 (chemical entity), MeSH:D008965.
• EMA: Not regulated as a medicinal product.
• Regulatory context: Molasses is unpatentable as a natural food product. No pharmaceutical company has commercial incentive to fund clinical trials. The absence of drug approval reflects economics, not safety concerns.

Ataraxia Verdict (as of 2026-04-15)

Evidence Classification (Mode 5: Evidence Classifier)

Hype Check (Mode 1: Fallacy Radar)

• Appeal to nature: Pervasive. "It's natural, whole food, not synthetic" — naturalness ≠ efficacy. Arsenic is natural.
• Appeal to tradition: "People have used it for centuries" — historical use ≠ clinical evidence. Bloodletting was traditional too.
• Hasty generalization: In vitro antioxidant activity → "fights disease." Grape molasses RCT → "blackstrap works." Pediatric data → adult efficacy.
• Cherry-picking: The single constipation RCT and iron absorption study are presented as comprehensive evidence. They're the ONLY evidence.
• Composition = efficacy fallacy: "Contains X mg of iron, therefore treats anemia." Compositional analysis ≠ clinical outcome.
• Misleading precision: The original file had 3,351 lines of detailed dosing protocols for a compound with 2 pediatric RCTs. The level of prescriptive detail (CKD staging, Child-Pugh classifications, cancer protocols) was disproportionate to the evidence base.

Evidence Gaps

• Zero adult RCTs for any indication
• Zero pharmacokinetic studies (mineral bioavailability from BSM in humans)
• Zero long-term safety data (>1 year)
• Zero microbiome studies
• Zero clinical antioxidant outcome studies
• Zero head-to-head vs ferrous sulfate in adults
• Zero dose-response studies
• The constipation RCT was not replicated

Bias Flags (Mode 4: First Principles)

• The only iron absorption study used grape molasses — a different product with different mineral/phenolic profiles. Extrapolating to blackstrap is an assumption.
• The constipation RCT was conducted at Shiraz University (Iran) in a journal with moderate impact — the science is sound (double-blind, randomized) but replication in Western populations would strengthen confidence.
• The GI-lowering study (PMID: 25373842) was funded by Horizon Science Pty. Ltd, which holds a patent on filtered molasses concentrate. Conflict of interest evident.
• Who benefits from molasses being popular? Small-scale producers, organic food brands, health food bloggers. The financial stakes are modest — this isn't a billion-dollar supplement industry. Which actually reduces manipulation risk.

Manipulation Flags (Mode 2: Manipulation Shield)

• Industry marketing: Minimal. Blackstrap molasses is a commodity food (~$5–8/bottle). No major supplement company markets it aggressively.
• Influencer economics: Moderate risk. Gray hair reversal and "cancer cure" claims drive YouTube/TikTok views. Several creators have built audiences around BSM content. Revenue is ad-based, not affiliate-based.
• Counter-narrative manipulation: None detected. No pharma company has reason to fearmonger against a cheap food product.
• Cui bono summary: Pro-molasses: health food content creators (modest), organic food brands (modest). Anti-molasses: nobody significant. The low commercial stakes actually make the folk evidence somewhat more credible — people aren't being paid to promote it.
• Red team highlight: The most concerning angle is that BSM's modest iron content (3.6 mg/tbsp) may provide just enough placebo reinforcement (via correcting subclinical iron deficiency in some users) to validate all the unproven claims. People who feel better from iron correction then attribute improvement to copper-mediated hair changes, "detoxification," and other folk claims.

Decision Support (Mode 3: Clarity Compass)

• General health utility: 3/10 — provides small amounts of minerals at a caloric cost of 58 kcal sugar per tablespoon
• Opportunity cost: Each tablespoon = 11 g added sugar toward WHO's 25 g/day ideal limit. Targeted mineral supplements deliver more mineral per calorie.
• Verdict: CONDITIONAL — only if: (a) mild iron deficiency + cannot tolerate ferrous sulfate, OR (b) pediatric functional constipation where PEG is not preferred
• Conditions: Ferritin 15–40 ng/mL + GI intolerance to iron tablets. Otherwise, skip.

Bottom Line

Blackstrap molasses is a legitimate whole-food iron source for a narrow population: people with mild iron deficiency who cannot tolerate standard supplements. One RCT supports it for pediatric constipation. Everything else — antioxidant benefits, bone health, cardiovascular effects, gray hair reversal, cancer prevention, "detoxification" — has zero human clinical evidence. The compound is safe (GRAS, no FAERS signals), cheap, and well-tolerated, but the evidence base does not justify the enthusiasm it receives on social media. If you're not iron-deficient and don't have a child with constipation, there's no evidence-based reason to take it.

Practical Notes

Brands & Product Selection

No USP/NSF certification exists for molasses. Quality markers: "unsulphured" on label, third-party heavy metal testing, clear country of origin (US/Caribbean/Brazil/India), glass jar preferred. Notable brands: Plantation (widely available, glass jar, ~$0.15–0.22/serving), Wholesome Sweeteners (USDA Organic, Fair Trade, ~$0.22–0.30), Grandma's Original (budget, ~$0.12–0.18), Golden Barrel (bulk options). Red flags: added corn syrup, no lot numbers, "detox" or "cures" claims on label.

Storage & Handling

Room temperature (15–25°C), dark cabinet, tightly sealed. NOT refrigerated (causes crystallization/thickening). Shelf life: 2–3 years unopened, 12–18 months opened. Wipe jar rim after use to prevent mold. Glass preferred over plastic for long-term. Crystallization is normal — warm gently to redissolve.

Palatability & Compliance

The #1 reason for discontinuation is taste aversion. Best masking strategies: (1) chocolate smoothie with cocoa powder, (2) stirred into hot oatmeal with cinnamon, (3) diluted in hot lemon water (also adds Vitamin C for iron absorption), (4) mixed into BBQ sauce or baked beans. Habit stack: place jar next to coffee maker or oatmeal container. Measure with actual tablespoon for consistency. Travel: decant 3 oz into TSA-compliant bottle for 1-week trip.

Exercise & Circadian Timing

No exercise-relevant effects. Not a pre/post-workout supplement. Morning or midday dosing preferred — evening sugar (11 g/tbsp) may disrupt sleep via insulin spike → nocturnal hypoglycemia → cortisol awakening in sensitive individuals. Hepcidin has a circadian rhythm (lowest in AM), so morning may slightly favor iron absorption.

Heavy Metal Contamination Risk

Moderate concern. Molasses can concentrate lead, arsenic, and cadmium from soil and processing equipment. Safe limits per serving (20 g): Pb <0.5 μg (Prop 65), As <10 ppb (EPA), Cd <4.1 μg (Prop 65). A November 2024 independent lab report (Tamara Rubin) found Plantation brand blackstrap molasses tested positive for lead (0.3 ppm — below food-grade limits but triggers CA Prop 65 warning), cadmium, and arsenic. Not recommended for children without third-party CoA verification. Choose brands with published Certificate of Analysis. Old processing equipment (pre-stainless steel) was a historical lead source — rare with modern manufacturing.

Cost

$0.08–0.30/serving depending on brand and organic status. For iron supplementation: molasses ($0.15/day) is cheaper than iron bisglycinate ($0.25–0.40/day) but more expensive than ferrous sulfate ($0.05/day). Molasses is NOT cost-effective for targeted mineral supplementation vs dedicated supplements (delivers far less mineral per dollar).

What We Don't Know

• Whether blackstrap molasses (not grape molasses) actually improves iron status in adults — never tested
• Human bioavailability of molasses-derived phenolics — zero PK data
• Long-term safety beyond 1 year of daily use
• Actual GI of blackstrap molasses (estimated at 55, never directly measured)
• Whether the pediatric constipation result replicates in adults or other populations
• Microbiome effects (prebiotic potential is theoretical only)
• Whether any of the 30+ phenolic compounds identified by Japanese researchers have clinical relevance in humans
• Optimal dose for any indication (no dose-response studies exist)
• Heavy metal content variation across brands (no comprehensive survey published)
• Whether copper content actually affects melanin synthesis at the dose delivered (hair graying claim)
• Interaction profile with common supplements beyond iron/calcium competition

References

Human Clinical Trials

1. Dehghani SM et al. (2019). RCT: Oral blackstrap molasses vs PEG for pediatric functional constipation. J Ethnopharmacol 238:111845. PMID: 30946967

   • Double-blind RCT, N=92 children 4–12 y, 4 weeks. BSM non-inferior to PEG. No side effects.

2. Aslan Y et al. (1997). Iron absorption from grape-molasses vs ferrous sulfate. Turk J Pediatr 39(4):465–71. PMID: 9433148

   • RCT, N=56 children 6–36 mo. Grape molasses comparable to FeSO₄ in non-anemic subjects; inferior in IDA group.

3. Wright AG, Ellis TP, Ilag LL. (2014). Filtered molasses concentrate lowers GI of high-carb foods. Plant Foods Hum Nutr 69(4):310–6. PMID: 25373842

   • Human crossover study. 5–20% postprandial glucose reduction. Industry-funded (Horizon Science). Processed extract, not standard BSM.

4. Ellis TP et al. (2015). Filtered sugarcane molasses concentrate and postprandial glycemia. PMID: 26410392

   • Related to PMID 25373842. FMC addition to foods reduces GI.

Milk-and-Molasses Enema Literature (Rectal Route — Not Oral)

5. Walker HK. (2011). Milk-and-molasses enemas vs sodium phosphate enemas in pediatric ER. PMID: 22134228
6. Herrle S. (2015). Milk-and-molasses enemas safety/efficacy in ED. PMID: 25850633
7. Carrier J et al. (2019). Milk-and-molasses enemas safety in hospitalized adults. PMID: 31408025
8. Walker HK. (2003). Cardiopulmonary compromise from milk-and-molasses enemas in children. PMID: 12500012
   • Safety case series — adverse events reported. Important safety data for rectal use.
9. Walker HK. (2012). Enema vs PEG 3350 for fecal disimpaction in children. PMID: 22270500

In Vitro / Compositional / Animal Studies

10. Valli V et al. (2012). Sugar cane and sugar beet molasses, antioxidant-rich alternatives. Food Chem 157:399–404. PMID: 23190112
11. Deseo MA et al. (2020). Antioxidant activity of sugarcane molasses extract. Food Chem 314:126180. PMID: 31954937
12. Guimarães CM et al. (2007). Antioxidant activity including DNA oxidative damage protection. PMID: 17995870
13. Asikin Y et al. (2013). Antioxidant fractions from sugarcane molasses (ORAC 4,399–6,266 μmol TE/g). Food Chem 141(1):466–72. PMID: 23768381
    • Kagoshima University. Bioassay-guided fractionation; 10 phenolic constituents identified.
14. Asikin Y et al. (2016). Neolignan glucosides from sugarcane molasses — DNA damage protection. J Sci Food Agric 96(4):1209–15. PMID: 25865605
    • University of the Ryukyus. First identification of neolignan glucosides in sugarcane molasses.
15. Takara K et al. (2003). New phenolic compounds from kokuto (non-centrifuged cane sugar). Biosci Biotechnol Biochem 67(2):376–9. PMID: 12729002
16. Takara K et al. (2002). Antioxidative phenolic glycosides from kokuto. Biosci Biotechnol Biochem 66(1):29–35. PMID: 11866116
17. Gultemirian ML et al. (2022). Cane molasses + oligofructose in hen diet improves egg/meat mineral content. Vet Anim Sci 16:100244. PMID: 35372706
18. Jain R, Venkatasubramanian P. (2017). Sugarcane molasses as dietary supplement for IDA management (narrative review). J Diet Suppl 14(5):589–601. PMID: 28125303
19. Nakamura Y et al. (2003). Black sugar and molasses effects on blood glucose/lipids in rats. Jpn J Nutr Diet 61(3):123–129.

Immunomodulation / Cardiovascular / Hepatoprotection / Stress

20. Hashemi Goradel N et al. (2019). Sugarcane molasses enhances TGF-β and FOXP3 by Bifidobacterium-stimulated PBMCs of UC patients. Iranian J Basic Med Sci. PMID: 31780030
    • Ex vivo human. Anti-inflammatory potential in ulcerative colitis.
21. Nishizawa M et al. (2009). Antiatherosclerotic function of Kokuto in Japanese quail. PMID: 19072226
    • Animal (quail). Phenolic compounds prevented atherosclerosis on atherogenic diet.
22. Chen Y et al. (2025). Sugarcane molasses polyphenol extract attenuates alcohol-induced liver damage in mice. Nutrients. PMID: 40362898
23. Asikin Y et al. (2019). Anti-stress and antioxidant effects of Kokuto in restraint-stressed mice. PMID: 30651413
    • Non-sugar fraction suppressed corticosterone and prevented antioxidant depletion.

Antibacterial / Compositional / Safety

24. Takara K et al. (2007). Antibacterial phenolics from sugarcane molasses vs cariogenic bacteria. PMID: 17938552
25. Phillips KM et al. (2009). Total antioxidant content of alternatives to refined sugar (USDA). PMID: 19103324
    • BSM highest ORAC (4,699 μmol TE/100 g) of all sweeteners tested.
26. Zhao Y et al. (2025). Hypoglycemic potential of sugarcane molasses polyphenols — alpha-glucosidase inhibition. PMID: 40390634
27. Seguí Gil L et al. (2024). Sugarcane flavonoids and phenolic acids: distribution, processing, health benefits. Compr Rev Food Sci Food Saf. PMID: 38369931
28. Chaves-López C et al. (2020). Characterization of molasses chemical composition. PMID: 32331893
29. Singh A et al. (2015). Phytochemical profile of sugarcane and health aspects. PMID: 26009693

General Mineral / Iron Science

20. Hurrell R, Egli I. (2010). Iron bioavailability and dietary reference values. Am J Clin Nutr 91(5):1461S–1467S. PMID: 20200263
21. Hallberg L et al. (1989). Iron absorption: ascorbic acid and phytate inhibition. Am J Clin Nutr 49(1):140–4. PMID: 2912000
22. Teucher B et al. (2004). Enhancers of iron absorption: ascorbic acid and organic acids. Int J Vitam Nutr Res 74(6):403–19. PMID: 15743017
23. Lönnerdal B. (2010). Calcium and iron absorption mechanisms. Int J Vitam Nutr Res 80(4–5):293–9. PMID: 21462112
24. Benvenga S et al. (2008). Altered levothyroxine absorption by coffee/iron. J Clin Endocrinol Metab 93(5):1961–5. PMID: 18270258
25. Zijp IM et al. (2000). Tea and dietary factors on iron absorption. Crit Rev Food Sci Nutr 40(5):371–98. PMID: 11029010
26. Aburto NJ et al. (2013). Potassium intake on CVD risk: systematic review + MA. BMJ 346:f1378. PMID: 23558164
27. Atkinson FS et al. (2008). GI and GL value tables. Diabetes Care 31(12):2281–3. PMID: 18835944

Databases & Authoritative Sources

28. USDA FoodData Central. Molasses, blackstrap. FDC ID: 167772.
29. NIH ODS. Iron Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
30. Institute of Medicine (2001). DRIs for Micronutrients. National Academies Press.